4 курс / Акушерство и гинекология / M_Капанадзе_Д_Л_Акушерские_и_перинатальные_исходы_у_беременных_с

91.Rand JH, Wu XX, Andree HA, Lockwood CJ, Guller S, Scher J, Harpel PC: Pregnancy loss in the antiphospholid-antibody syndrome – a possible thrombogenic mechanism. N Engl J Med 1997, 337:154-160.

92.Rai RS, Clifford K, Cohen H, Regan L: High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995, 10:3301-3304.

93.Roberts JM, Taylor RN, Musici TJ, Rodgers GM, Hubel CA, McLaughlin

94. Rai R, Tuddenham E, Backos M, Regan L: Pre-pregnancy thrombophilic abnormalities are associated with subsequent spontaneous abortion. Hum Reprod 2000, 15:168.

95. Regan L, Rai R: Thrombophilia and pregnancy loss. J Reprod Immunol 2002, 55:163-180.

96.Rai R, Cohen H, Dave M, Regan L: Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997, 314:253-

97.Rosove M.H. , Brewer P.M. Antiphospholipid thrombosis-clinical course after the first thrombotic event in 70 patients. Ann Inter Med.1992 Aug15,117 (4) 303-8

98.Sanna G, D'Cruz D, Cuadrado MJ (August 2006). "Cerebral manifestations in the antiphospholipid (Hughes) syndrome". Rheum. Dis. Clin. North Am. 32 (3): 465–90.

99.Scarvelis D, Wells PS (October 2006). "Diagnosis and treatment of deep-vein thrombosis". CMAJ175 (9):108792.

111

100.Svensson PJ, Dahlback B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994, 330:517-552.

101.Seligsohn U, Zivelin A: Thrombophilia As a Multigenic Disorder. Thromb Haemost 1997, 78:297-301. P

103.Shanklin DR, Sibai BM: Ultrastructural aspects of preeclampsia. Am J Obstet Gynecol 1989, 161:735-741.

104.Salafia CM, Minior VK, Pezzulo JC, Popek EJ, Rosenkrantz TS, Vintzileos AM: Intrauterine growth restriction in infants of less than thirty-two weeks'

107.Stephenson MD, Ballem PJ, T sang P, Purkiss S, Houlihan E, Enson MH. Treatment of Antiphospholipid antibody syndrome (APS) in pregnancy: a random pilot total comparing low molecular weight Heparin to unfractionated Heparin. J Obstet Gynacol Can 2004;26:729–34

108.Shannon M. Bates, Ian A. Grear, Jack Hirsh, Jerry S. Ginsberg use of antithrombotic agents during pregnancy. Chest J 2004;126:627–44.

112

109.Tulppala M, Viinikka L, Ylikorkala O: Thromboxane dominance and prostacyclin deficiency in habitual abortion. Lancet 1991, 337:879-881.

110.Vincent T, Rai R, Regan L, Cohen H: Increased thrombin generation in women with recurrent miscarriage. Lancet 1998, 352:116.

111.Yetman DL, Kutteh WH: Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 1996, 66:540-546.

112.Yasuda M, Takakuwa K, Tokunaga A, Tanaka K: Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995, 86:555-559.

113.Woodhams J, Candotti G, Shaw R, Kernoff PBA: Changes in coagulation and fibrinolysis during pregnancy: evidence of activation of coagulation preceding spontaneous abortion. Thromb Res 1989, 55:99-107.

114.Walh D.G. Guillemim F. de Maistre E. Perret-Guillaume C. Lecomte T. Thibaut G. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus.1998,7(1) 15-22.

113